» Articles » PMID: 15196310

Jejunal Microvilli Atrophy and Reduced Nutrient Transport in Rats with Advanced Liver Cirrhosis: Improvement by Insulin-like Growth Factor I

Abstract

Background: Previous results have shown that in rats with non-ascitic cirrhosis there is an altered transport of sugars and amino acids associated with elongated microvilli. These alterations returned to normal with the administration of Insulin-Like Growth Factor-I (IGF-I). The aims of this study were to explore the evolution of these alterations and analyse the effect of IGF-I in rats with advanced cirrhosis and ascites. Thus, jejunal structure and nutrient transport (D-galactose, L-leucine, L-proline, L-glutamic acid and L-cystine) were studied in rats with ascitic cirrhosis.

Methods: Advanced cirrhosis was induced by CCl4 inhalation and Phenobarbital administration for 30 weeks. Cirrhotic animals were divided into two groups which received IGF-I or saline during two weeks. Control group was studied in parallel. Jejunal microvilli were studied by electron microscopy. Nutrient transport was assessed in brush border membrane vesicles using 14C or 35S-labelled subtracts in the three experimental groups.

Results: Intestinal active Na+-dependent transport was significantly reduced in untreated cirrhotic rats. Kinetic studies showed a decreased Vmax and a reduced affinity for sugar and four amino acids transporters (expressed as an increased Kt) in the brush border membrane vesicles from untreated cirrhotic rats as compared with controls. Both parameters were normalised in the IGF-I-treated cirrhotic group. Electron microscopy showed elongation and fusion of microvilli with degenerative membrane lesions and/or notable atrophy.

Conclusions: The initial microvilli elongation reported in non ascitic cirrhosis develops into atrophy in rats with advanced cirrhosis and nutrient transports (monosaccharides and amino acids) are progressively reduced. Both morphological and functional alterations improved significantly with low doses of IGF-I.

Citing Articles

Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF - An Open Label Randomized Clinical Trial.

Mehtani R, Premkumar M, Garg S, Kajal K, Kulkarni A, Duseja A J Clin Exp Hepatol. 2023; 13(6):977-988.

PMID: 37975059 PMC: 10643498. DOI: 10.1016/j.jceh.2023.05.015.


Is insulin-like growth factor-1 involved in Parkinson's disease development?.

Castilla-Cortazar I, Aguirre G, Femat-Roldan G, Martin-Estal I, Espinosa L J Transl Med. 2020; 18(1):70.

PMID: 32046737 PMC: 7014772. DOI: 10.1186/s12967-020-02223-0.


Comparative Proteomic Analysis of Two Differently Extracted Coptis chinensis in the Treatment of Type 2 Diabetic Rats.

Qiu X, Wei X, Guan H, Su H, Gong J, Fang K Evid Based Complement Alternat Med. 2018; 2018:3248521.

PMID: 30302116 PMC: 6158947. DOI: 10.1155/2018/3248521.


Changes of Intestinal Functions in Liver Cirrhosis.

Fukui H, Wiest R Inflamm Intest Dis. 2018; 1(1):24-40.

PMID: 29922655 PMC: 5988129. DOI: 10.1159/000444436.


Experimental approach to IGF-1 therapy in CCl-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency.

Morales-Garza L, Puche J, Aguirre G, Munoz U, Garcia-Magarino M, de la Garza R J Transl Med. 2017; 15(1):96.

PMID: 28472963 PMC: 5418730. DOI: 10.1186/s12967-017-1198-4.


References
1.
Ciclitira P, Ellis H . In vivo gluten ingestion in coeliac disease. Dig Dis. 1999; 16(6):337-40. DOI: 10.1159/000016887. View

2.
Castilla-Cortazar I, Garcia M, Quiroga J, Diez N, Diez-Caballero F, Calvo A . Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis. Hepatology. 2000; 31(3):592-600. DOI: 10.1002/hep.510310308. View

3.
Pascual M, Castilla-Cortazar I, Urdaneta E, Quiroga J, Garcia M, Picardi A . Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I. Am J Physiol Gastrointest Liver Physiol. 2000; 279(2):G319-24. DOI: 10.1152/ajpgi.2000.279.2.G319. View

4.
Hattori N, Kurahachi H, Ikekubo K, Ishihara T, MORIDERA K, Hino M . Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosis. Metabolism. 1992; 41(4):377-81. DOI: 10.1016/0026-0495(92)90071-h. View

5.
Kondrup J, Nielsen K, Hamberg O . Nutritional therapy in patients with liver cirrhosis. Eur J Clin Nutr. 1992; 46(4):239-46. View